Provided by Tiger Trade Technology Pte. Ltd.

Cohen & Steers

72.34
-1.7700-2.39%
Post-market: 72.340.00000.00%19:30 EDT
Volume:360.17K
Turnover:26.25M
Market Cap:3.72B
PE:22.26
High:74.34
Open:74.27
Low:72.33
Close:74.11
52wk High:86.56
52wk Low:58.39
Shares:51.39M
Float Shares:27.75M
Volume Ratio:1.07
T/O Rate:1.30%
Dividend:2.58
Dividend Rate:3.57%
EPS(TTM):3.25
EPS(LYR):2.97
ROE:27.33%
ROA:14.54%
PB:6.31
PE(LYR):24.36

Loading ...

Silo Pharma Granted European Patent Covering Novel PTSD Therapy

GlobeNewswire
·
Aug 10

Axsome Therapeutics (AXSM) Could Be 25% Undervalued As CNS Pipeline Hopes Build

Simply Wall St.
·
Aug 10

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 07

Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium

GlobeNewswire
·
Aug 06

Press Release: Nuvation Bio Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 06

LG CNS Secures Project to Develop AI Roadmap for 14 Airports in Korea

MT Newswires Live
·
Aug 06

Tonix Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Aug 05

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 05

Press Release: Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale

Dow Jones
·
Aug 03

Cohen & Steers Q2 FY26 Net Income Climbs 33.9% to $49.34 Million

Reuters
·
Jul 31

Press Release: Cerenome Launches as an Integrated CNS Oncology Company

Dow Jones
·
Jul 31

LG CNS' Attributable Net Income Rises 20% in Q2; Shares Up 6%

MT Newswires Live
·
Jul 31

LG CNS' Attributable Net Income Rises 20% in Q2

MT Newswires Live
·
Jul 31

Cohen & Steers Keeps Quarterly Dividend at $0.67 a Share, Payable Aug. 20 to Holders of Record Aug. 10

MT Newswires Live
·
Jul 31

Cohen & Steers Declares USD 0.67 Quarterly Dividend for Q3 2026

Reuters
·
Jul 31

Cohen & Steers, Inc. Declares Quarterly Dividend

THOMSON REUTERS
·
Jul 31

Cellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026

GlobeNewswire
·
Jul 30

Press Release: Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Jul 30

Dyne Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights

GlobeNewswire
·
Jul 30

Cohen & Steers Closed-end Opportunity Fund Shifts 80% Policy to Exchange-listed Closed-end Vehicles Effective Oct. 1, 2026

Reuters
·
Jul 30